Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13809001 | 0.95 | LTA4H (0.74) | LTA4HCHRNA3 | |
| Hydrochloric Acid SCHEMBL4316710 | 0.94 | LTA4H (0.72) | LTA4HCHRNA3 | |
| Hydrochloric Acid SCHEMBL4316713 | 0.94 | LTA4H (0.72) | LTA4HCHRNA3 | |
| SCHEMBL11458950 | 0.86 | LTA4H (0.50) | LTA4HCHRNA3 | |
| SCHEMBL14541911 | 0.83 | CHRNA3 (0.68) | LTA4HCHRNA3 | |
| SCHEMBL2202052 | 0.83 | LTA4H (0.91) | LTA4HCHRNA3 | |
| SCHEMBL6535790 | 0.83 | LTA4H (0.66) | LTA4HCHRNA3 | |
| SCHEMBL15300994 | 0.83 | LTA4H (0.66) | LTA4HCHRNA3 | |
| SCHEMBL6535709 | 0.83 | LTA4H (0.66) | LTA4HCHRNA3 | |
| SCHEMBL10326507 | 0.83 | LTA4H (0.66) | LTA4HCHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080027035-A1 | Dpp-Iv Inhibitors | GRAFFINITY PHARMACEUTICALS AG (DE) | 2008-01-31 | — | — | US | disclosed |
| US-20080027035-A1 | Dpp-Iv Inhibitors | GRAFFINITY PHARMACEUTICALS AG (DE) | 2008-01-31 | — | — | US | disclosed |
| EP-1613304-B1 | DPP-IV INHIBITORS | SANTHERA PHARMACEUTICALS CH (CH) | 2007-09-12 | — | — | EP | disclosed |
| WO-2005056003-A1 | DPP-IV INHIBITORS | SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH (CH) | 2005-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027035-A1 | Dpp-Iv Inhibitors | DPP4, DPP7, DPP3 | LTA4H 1037/4885CHRNA3 2401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.